CDC Logo Skip Top Nav
 CDC Home PageSearch the CDCHealth Topics A though Z
Skip
Division of Tuberculosis Elimination
About DTBE Upcoming Events Site Map CDC en Espanol Contact Us
 
Skip the Contents menu

Contents

Skip the Resources menu

Resources



U.S. Department of Health and Human Services
 
 

Mycobacteriology Laboratory Branch

Return to Mycobacteriology Laboratory Main Page

Drug susceptibility testing

Drug susceptibility testing is a difficult procedure to standardize, and proficiency in performing these tests requires an understanding of many elements, including the

  • Origin of drug resistance and the criteria for resistance
  • Potency and stability of drugs during laboratory manipulation
  • Antimycobacterial activity of drugs when incorporated into different media
  • Reading, interpretation, and reporting of results

The MLB uses an indirect proportion method for testing M. tuberculosis and other slow-growing mycobacteria to 11 drugs at 35°C on Middlebrook 7H10 agar. The test requires 1 month to complete.  Growth on the control medium is compared to the growth on the drug-containing medium to determine susceptibility or resistance. When performed properly, this method allows a quantitation of the proportion of mutants resistant to a drug and can detect the 1% proportion of drug- resistant mutants above which therapeutic failure is likely.

Slow growing mycobacteria are tested with the following drugs:

  • Isoniazid
  • Streptomycin
  • Ciprofloxacin
  • Capreomycin
  • Kanamycin
  • Pyrazinamide
  • Cycloserine
  • Ethambutol
  • Rifampin
  • Ethionamide
  • Rifabutin

Last Reviewed: 05/18/2008
Content Source: Division of Tuberculosis Elimination
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention

 

 
Back to Top of Page


If you would like to order any of the DTBE publications please visit the online order form.

You will need Adobe Acrobat™ Reader v5.0 or higher to read pages that are in PDF format.  Download the Adobe Acrobat™ Reader.

If you have difficulty accessing any material on the DTBE Web site because of a disability, please contact us in writing or via telephone and we will work with you to make the information available.

Division of Tuberculosis Elimination
Attn: Content Manager, DTBE Web site
Centers for Disease Control and Prevention
1600 Clifton Rd., NE Mailstop E-10
Atlanta, GA 30333
CDC-INFO at (1-800) 232-4636
TTY: 1 (888) 232-6348
E-mail: cdcinfo@cdc.gov


Skip Bottom Nav Home | Site Map | Contact Us
Accessibility | Privacy Policy Notice | FOIA | USA.gov
CDC Home | Search | Health Topics A-Z

Centers for Disease Control & Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Division of Tuberculosis Elimination
Please send comments/suggestions/requests to: CDCINFO@cdc.gov